Impairment of MLHI and CDKN2A in oncogenesis of laryngeal cancer

British Journal of Cancer

Volumn 90, Issue 8, 2004, Pages 1594-1599

  Sasiadek, M M ^a   Stembalska Kozlowska, A ^a   Smigiel, R ^a   Ramsey, D ^b   Kayademir, T ^c   Blin, N ^c  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

^b WROCLAW UNIVERSITY OF TECHNOLOGY   (Poland)

^c UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

CDKN2A (p16); LSCC; MLHI; RBI

Indexed keywords

MOLECULAR MARKER; PROTEIN MLH1; CARRIER PROTEIN; DNA; MLH1 PROTEIN, HUMAN; NUCLEAR PROTEIN; PROTEIN P16INK4A; TUMOR MARKER; TUMOR PROTEIN;

ADULT; ARTICLE; CANCER GRADING; CANCER GROWTH; CANCER STAGING; CARCINOGENESIS; CHROMOSOME PAIRING; DNA METHYLATION; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENE SILENCING; GENETIC CORRELATION; GENETIC DAMAGE; HEAD AND NECK CARCINOMA; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; HYPOTHESIS; LARYNX CANCER; MAJOR CLINICAL STUDY; MALE; ONCOGENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; AGED; BASE MISPAIRING; CELL TRANSFORMATION; DISEASE COURSE; GENE EXPRESSION REGULATION; GENETICS; LARYNX TUMOR; MIDDLE AGED; PATHOLOGY; TUMOR SUPPRESSOR GENE;

ADULT; AGED; BASE PAIR MISMATCH; CARCINOMA, SQUAMOUS CELL; CARRIER PROTEINS; CELL TRANSFORMATION, NEOPLASTIC; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DISEASE PROGRESSION; DNA, NEOPLASM; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, P16; HUMANS; LARYNGEAL NEOPLASMS; LOSS OF HETEROZYGOSITY; MALE; MIDDLE AGED; NEOPLASM PROTEINS; NUCLEAR PROTEINS; TUMOR MARKERS, BIOLOGICAL;

EID: 2442555087     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6601679     Document Type: Article

References (44)

1. Ah-See K, Cooke TG, Pickford IR, Soutar D, Balmain A (1994) An allelotype of squamous carcinoma of the head and neck using microsatellite markers. Cancer Res 54: 1617-1621
2. Arzimanoglou II, Hansen LL, Chong D, Li Z, Psaroudi MC, Dimitrakakis C, Jacovina AT, Shevchuk M, Reid L, Hajjar KA, Vassilaros S, Michalas S, Gilbert F, Chervenak FA, Barber HR (2002) Frequent LOH at hMLH1, a highly variable SNP in hMSH3, and negligible coding instability in ovarian cancer. Anticancer Res 22: 969-975
3. Bergamo NA, Rogatto SR, Poli-Federico RC, Reis PP, Kowalski LP, Yielenska M, Squire A (2000) Comparative genomic hybridization analysis detects frequent over-representation of DNA sequences at 3q, 7p and 8q in head and neck carcinomas. Cancer Genet Cytogenet 119: 48-55
4. Califano J, van der Riet P, Westra W, Nawroz H, Clayman G, Piantadosi S, Corio R, Lee D, Greenberg B, Koch W, Sidransky D (1996) Genetic progression model for head and neck cancer: implications for field cancerization. Cancer Res 56: 2488-2492
5. Carvalho R, Kayademir T, Soares P, Canedo P, Sousa S, Oliveira C, Leistenschneider P, Carneiro F, Gött P, Blin N, Seruca R, Machado JC (2002) LOH and promoter methylation, but not mutation, may underlie loss of TFF1 in gastric carcinoma. Lab Invest 82: 1319-1326
6. Crowe DL, Hacia JG, Hsieh C-L, Sinha UK, Rice DH (2002) Molecular pathology of head and neck cancer. Histol Histopathol 17: 909-914
7. Deng G, Chen A, Hong J, Chae HS, Kim YS (1999) Methylation of CpG in a small region of the hMLH1 promoter invariably correlates with the absence of gene expression. Cancer Res 59: 2029-2033
8. dos Reis PP, Poli-Federico RC, dos Santos RM, Nishimoto IN, Kowalski LP, Rogatto SR (2002) Distinct regions of loss of heterozygosity on 22q in different sites of head and neck squamous cell carcinomas. Med Sci Monit 8: BR89-BR94
9. El-Naggar AK, Lai S, Clyman G, Lee JKJ, Luna MA, Goepfert H, Batsakis JG (1997) Methylation, a major mechanism of p16/CDKN2 gene inactivation in head and neck squamous carcinoma. Am J Path 151: 1767-1773
10. Fan CY (2001) Genetic alterations in head and neck cancer: interactions among environmental carcinogens, cell cycle control, and host DNA repair. Curr Oncol Rep 3: 66-71
11. Fiedler W, Hoppe C, Schimmel B, Koscielny S, Dahse R, Bereczki Y, Claussen U, Ernst G, von Eggeling F (2002) Molecular characterization of head and neck tumors by analysis of telomerase activity and a panel of microsatellite markers. Int J Mol Med 9: 417-423
12. Fujiwara Y, Ohata H, Kuroki T, Koyama K, Tsuchiya E, Monden M, Nakamura Y (1995) Isolation of a candidate tumor suppressor gene on chromosome 8p21.3-p22 that is homologous to an extracellular domain of the PDGF receptor beta gene. Oncogene 10: 891-895
13. Gallo O, Franchi A, Chiarelli I, Porfirio B, Grande A, Simonetti L, Bocciolini C, Fini-Storchi O (1997) Potential biomarkers in predicting progression of epithelial hyperplastic lesions of the larynx. Acta Otolaryngol Suppl 527: 30-38
14. Giannini G, Ristori E, Cerignoli F, Rinaldi C, Zani M, Viel A, Ottin L, Crescenzi M, Martinotti S, Bignami M, Frati L, Screpanti I (2002) Human MRE11 is inactivated in mismatch repair-deficient cancers. EMBO Rep 3: 248-254
15. Gleich LL, Li YQ, Wang X, Stambrook PJ, Gluckman JL (1999) Variable genetic alterations and survival in head and neck cancer.. Head Neck Surg 125: 949-952
16. Grati FR, Sirchia SM, Garagiola, Sironi E, Galioto S, Rossella F, Serafini P, Dulcetti F, Bozzetti A, Brusati R, Simoni G (2000) Losses of heterozygosity in oral and oropharyngeal epithelial carcinomas. Cancer Genet Cytogenet 118: 57-61
17. Gunduz M, Ouchida M, Fukushima K, Ito S, Jitsumori Y, Nakashima T, Nagai N, Nishizaki K, Shimizu K (2002) Allelic loss and reduced expression of the ING3, a candidate tumor suppressor gene at 7q31, in human head and neck cancers. Oncogene 21: 4462-4470
18. Herman JG, Graff JR, Myohanen S, Nelkin BD, Baylin SB (1996) Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 93: 9821-9826
19. Höglund M, Gisselsson D, Mandahl N, Johansson B, Mertens F, Mitelman F, Säll T (2001) Multivariate analyses of genomic imbalances in solid tumors reveal distinct and converging pathways of karyotypic evolution. Genet Chromosomes Cancer 31: 156-171
20. Huang Q, Yu GP, McCormick SA, Mo J, Datta B, Mahimkar M, Lazarus P, Schäffer AA, Desper R, Schantz SP (2002) Genetic differences detected by comparative genomic hybridisation in head and neck squamous cell carcinomas from different tumor sites: construction of oncogenetic trees for tumor progression. Genes Chromosomes Cancer 34: 224-233
21. Jin Y, Higashi K, Mandahi N, Heim S, Wennerberg J, Biorklund A, Dictor M, Mitelman F (1990) Frequent rearrangement of chromosomal bands Ip22 and 11q12 in squamous cell carcinomas of head and neck. Genes Chromosomes Cancer 2: 198-204
22. Karnik P, Paris M, Williams BRG, Casey G, Crowe J, Chen P (1998) Two distinct tumor suppressor loci within chromosome 11p15 implicated in breast cancer progression and metastasis. Hum Mol Genet 7: 895-903
23. Kujawski M, Sariomo-Rikala M, Gabriel A, Szyfter K, Knuutila S (1999) Recurrent DNA copy number losses associated with metastasis of larynx carcinoma. Genes Chromosomes Cancer 26: 253-257
24. Lang JC, Borchers J, Danahey D, Smith S, Stover DG, Agrawal A, Malone JP, Schuller DE, Weghorst CM, Holinga AJ, Lingam K, Patel CR, Esham B (2002) Mutational status of overexpressed p16 in head and neck cancer evidence for germline mutation of p16/p14ARF. Int J Oncol 21: 401-408
25. Li X, Lee NK, Ye Y-W, Waber PG, Schweizer C, Cheng Q-C, Nisen PD (1994) Allelic loss at chromosomes 3p, 8p, 13q and 17p associated with poor prognosis in head and neck cancer. J Natl Cancer Inst 86: 1524-1529
26. Mannila (1997) Methods and problems in data mining. Afrati F, Kolaitis P (eds) The Proceedings of the International Conference on Database Theory, Delphi, Greece: Springer
27. Matsuura K, Shiga K, Yokoyama J, Saijo S, Miyagi T, Takasaka T (1998) Loss of heterozygosity of chromosome 9p21 and 7q31 is correlated with high incidence of recurrent tumor in head and neck squamous cell carcinoma. Anticancer Res 18: 453-458
28. Nawroz H, van der Riet, Hruban RH, Koch WM, Ruppert JM, Sidransky D (1994) Allelotype of head and neck squamous cell carcinoma. Cancer Res 54: 1152-1155
29. Oba K, Matsuyama H, Yoshihiro S, Kishi F, Takahashi M., Tsukamoto M., Kinjo M., Sagiyama K, Naito K (2001) Two putative tumor suppressor genes on chromosome arm 8p may play different roles in prostate cancer. Cancer Genet Cytogenet 124: 20-26
30. Papadimitrakopoulou VA (2000) Carcinogenesis of head and neck cancer and the role of chemoprevention in its reversal Curr Opin Oncol 12: 240-245
31. Ransom DT, Barnett TC, Bot J, de Boer B, Mercalf C, Davidson JA, Turbett GR (1998) Loss of heterozygosity on chromosome 2q: possibly a poor prognostic factor in head and neck cancer. Head Neck 20: 404-410
32. Rainho CA, Kowalski LP, Rogatto SR (2001) Loss of imprinting and loss of heterozygosity on 11p15.5 in head and neck squamous cell carcinomas. Head Neck 23: 851-859
33. Renan MJ (1993) How many mutations are required for tumorigenesis? Implications from human cancer data. Mol Carcinogen 7: 139-146
34. Sasiadek M, Stembalska-Kozlowska A, Smigiel R, Schlade-Bartusiak K, Kupka S, Jagielski J, Krecicki T, Ramsey D, Mirghomizadeh F, Blin N (2002) Genetic instability in cancer: microsatellite and chromosomal instability in larynx squamous cell carcinoma. Int J Mol Med, (Suppl 1): 39
35. Scholnick SB, Haughey BH, Sunwoo JB, El-Mofty SK, Baty JD, Piccirillo JF, Zequeira MR (1996) Chromosome 8 allelic loss and the outcome of patients with squamous cell carcinoma of the supraglottic larynx. J Natl Cancer Inst 88: 1676-1681
36. Seifert M, Thesinger B, Engel M, Seib T, Seiz T, Stolte M, Hilgert K, Welter C (1997) Isolation and characterization of new microsatellites at the nm23-H1 and nm23-H2 gene loci and application for loss of heterozygosity (LOH) analysis. Hum Genet 100: 515-519
37. Sherr CJ (1996) Cancer cell cycles. Sciences 274: 1672-1677
38. Soder AI, Hopman AHN, Ramaekers FCS, Conradt C, Bosch FX (1995) Distinct nonrandom patterns of chromosomal aberrations in the progression of squamous cell carcinomas of the head and neck. Cancer Res 55: 5030-5037
39. Sturgis EM, Wei Q (2002) Genetic susceptibility-molecular epidemiology of head and neck cancer. Curr Opin Oncol 14: 310-317
40. Tsuda H, Takarabe T, Okada S, Uchida H, Kasamatsu T, Yamada Tsunematsu R, Ohmi K, Hirohashi S (2002) Different pattern of loss of heterozygosity among endocervicaltype adenocarcinoma, endometrioidtype adenocarcinoma and adenoma malignum of uterine cervix. Int J Cancer 98: 713-717
41. Van Dyke DL, Worsham MJ, Benninger MS, Krause CJ, Baker SR, Wolf GT, Drumheller T, Tilley BC, Carey TE (1994) Recurrent cytogenetic abnormalities in squamous cell carcinomas of the head and neck region. Genes Chromosomes Cancer 9: 192-206
42. Voravud N, Charurukus N, Mutirangura A (1997) Squamous cell carcinoma of head and neck. J Med Assoc Thai 80: 207-218
43. Wheeler JMD, Beck NE, Kim HC, Tomlinson IPM, Mortensen NJMcC (1999) Mechanisms of inactivation of mismatch repair genes in human colorectal cancer cell lines: the prominent role of IMLH1. Proc Natl Acad Sci USA 96: 10296-10301
44. Yokoyama J, Shiga K, Sasano H, Suzuki M, Takasaka T (1996) Abnormalities and the implication of retinoblastoma locus and its protein product in head and neck cancers. Anticancer Res 16: 641-644